RhumbLine Advisers’s Guardian Pharmacy Services GRDN Stock Holding History

RhumbLine Advisers’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$990K	Sell	23,656 -2,044	-8%	-$79.1K	﹤0.01%	2319
2026 Q1	$968K	Buy	25,700 +549	+2%	+$17.9K	﹤0.01%	2209
2025 Q4	$757K	Buy	25,151 +4,056	+19%	+$115K	﹤0.01%	2384
2025 Q3	$553K	Buy	21,095 +4,921	+30%	+$117K	﹤0.01%	2629
2025 Q2	$345K	Buy	16,174 +8,860	+121%	+$200K	﹤0.01%	2908
2025 Q1	$155K	Sell	7,314 -55	-0.7%	-$1.13K	﹤0.01%	3228
2024 Q4	$149K	Buy	+7,369	New	+$152K	﹤0.01%	3338

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

RhumbLine Advisers's GRDN Position: Q2 2026 in Review

RhumbLine Advisers reduced its Guardian Pharmacy Services (GRDN) stake by 8% in Q2 2026, selling an estimated $79.1K and leaving 23,656 shares worth $990K. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

RhumbLine Advisers first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

RhumbLine Advisers held 23,656 shares of Guardian Pharmacy Services worth $990K as of Q2 2026.
RhumbLine Advisers sold 2,044 Guardian Pharmacy Services shares in Q2 2026, an estimated $79.1K.
Guardian Pharmacy Services made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2319 holding.
RhumbLine Advisers first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.